JP2004536108A - アセクロフェナックを含有する経済的な経口用製剤の組成及び製法 - Google Patents

アセクロフェナックを含有する経済的な経口用製剤の組成及び製法 Download PDF

Info

Publication number
JP2004536108A
JP2004536108A JP2003510069A JP2003510069A JP2004536108A JP 2004536108 A JP2004536108 A JP 2004536108A JP 2003510069 A JP2003510069 A JP 2003510069A JP 2003510069 A JP2003510069 A JP 2003510069A JP 2004536108 A JP2004536108 A JP 2004536108A
Authority
JP
Japan
Prior art keywords
aceclofenac
preparation
acid
weight
parts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003510069A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004536108A5 (https=
Inventor
リー，ボム−ジン
リー，ドン−ウォン
キム，テ−ワン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2004536108A publication Critical patent/JP2004536108A/ja
Publication of JP2004536108A5 publication Critical patent/JP2004536108A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2003510069A 2001-07-03 2002-06-25 アセクロフェナックを含有する経済的な経口用製剤の組成及び製法 Pending JP2004536108A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2001-0039387A KR100425226B1 (ko) 2001-07-03 2001-07-03 아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법
PCT/KR2002/001210 WO2003004060A1 (en) 2001-07-03 2002-06-25 Compositions and preparation methods for bioavailable oral aceaceclofenac dosage forms

Publications (2)

Publication Number Publication Date
JP2004536108A true JP2004536108A (ja) 2004-12-02
JP2004536108A5 JP2004536108A5 (https=) 2005-09-29

Family

ID=19711694

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003510069A Pending JP2004536108A (ja) 2001-07-03 2002-06-25 アセクロフェナックを含有する経済的な経口用製剤の組成及び製法

Country Status (6)

Country Link
US (1) US20040180961A1 (https=)
EP (1) EP1409023A1 (https=)
JP (1) JP2004536108A (https=)
KR (1) KR100425226B1 (https=)
CN (1) CN1543359A (https=)
WO (1) WO2003004060A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011528666A (ja) * 2008-07-18 2011-11-24 バレアント プハルマセウトイカルス インターナショナル 放出調節製剤及びその使用方法
JP2017014189A (ja) * 2015-06-29 2017-01-19 永信藥品工業股▲ふん▼有限公司 固体剤形で非常に難溶性の薬物を調製する方法

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE395044T1 (de) 2002-02-01 2008-05-15 Pfizer Prod Inc Pharmazeutische zusammensetzungen amorpher dispersionen von wirkstoffen und lipophiler mikrophasenbildender materialien
EP1920766B1 (en) * 2002-02-01 2017-08-23 Bend Research, Inc Pharmaceutical compositions of amorphous dispersions of drugs and lipophilic microphase-forming materials
JP2007501218A (ja) 2003-08-04 2007-01-25 ファイザー・プロダクツ・インク 非晶質薬物の吸着物および親油性ミクロ相形成物質の医薬組成物
US20060019933A1 (en) * 2004-07-22 2006-01-26 David Boardman Process for preparing stabilized vitamin D
ATE476962T1 (de) * 2004-11-22 2010-08-15 Venus Remedies Ltd Nichtwässrige flüssige parenterale aceclofenac- formulierung
CN1301709C (zh) * 2005-02-17 2007-02-28 西安东盛集团有限公司 一种含醋氯芬酸的皮肤用贴剂
KR100806541B1 (ko) * 2005-05-11 2008-02-26 한국유나이티드제약 주식회사 아세클로페낙을 함유하는 제어 방출성 제제
GB0613925D0 (en) * 2006-07-13 2006-08-23 Unilever Plc Improvements relating to nanodispersions
US8685457B2 (en) * 2007-06-06 2014-04-01 Basf Se Pharmaceutical formulation for the production of rapidly disintegrating tablets
KR100911517B1 (ko) * 2007-08-31 2009-08-10 주식회사 드림파마 신규한 서방출형 아세클로페낙 제제 조성물 및 그의제조방법
KR101003204B1 (ko) * 2008-02-14 2010-12-21 메콕스큐어메드 주식회사 약물 전달용 고형 지질 나노입자, 그 제조방법, 및 그나노입자를 포함하는 주사제
AR071375A1 (es) * 2008-04-22 2010-06-16 Solvay Pharm Gmbh Formulaciones para ingredientes farmaceuticos activos de permeabilidad deficiente, proceso de preparacion y producto
US20090281136A1 (en) * 2008-05-08 2009-11-12 Sandeep Mhetre Prasugrel pharmaceutical formulations
KR100986531B1 (ko) * 2008-07-18 2010-10-07 한국콜마 주식회사 액상의 아세클로페낙을 함유하는 캡슐제
KR101018894B1 (ko) * 2008-08-27 2011-03-04 근화제약주식회사 체내 흡수가 증진된 탈니플루메이트 함유 서방정
US20110229527A1 (en) * 2008-11-20 2011-09-22 Nandu Deorkar Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient
KR101050076B1 (ko) * 2009-02-04 2011-07-19 한국유나이티드제약 주식회사 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법
KR101234254B1 (ko) * 2010-06-01 2013-02-18 한국유나이티드제약 주식회사 1일 1회 투여로 최적의 약리학적 임상 효과를 제공하는 아세클로페낙 서방성 제제
RU2686183C2 (ru) * 2014-01-21 2019-04-24 БиПиЭсАй ХОЛДИНГЗ, ЭлЭлСи Пленочные покрытия быстрого высвобождения, содержащие среднецепочечные глицериды, и покрытые ими субстраты
KR102840190B1 (ko) * 2022-04-19 2025-07-29 (의) 삼성의료재단 생리활성물질 전달체

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756450A (en) * 1987-09-15 1998-05-26 Novartis Corporation Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
JPH08157362A (ja) * 1994-12-06 1996-06-18 Sankyo Co Ltd 油性物質含有固形製剤の製法
KR100239799B1 (ko) * 1995-01-21 2000-02-01 손경식 경구투여용 사이클로스포린 에이 고체미셀분산체, 이의 제조 방법 및 고형제제
SE9600070D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral pharmaceutical dosage forms
KR100320361B1 (ko) * 1998-05-08 2002-05-13 류덕희 비스테로이드성소염진통약물의마이크로에멀젼외용제
KR100336090B1 (ko) * 1998-06-27 2002-05-27 윤승원 오일, 지방산 또는 이들의 혼합물을 함유한 난용성 약물의 고형분산제제
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011528666A (ja) * 2008-07-18 2011-11-24 バレアント プハルマセウトイカルス インターナショナル 放出調節製剤及びその使用方法
JP2017014189A (ja) * 2015-06-29 2017-01-19 永信藥品工業股▲ふん▼有限公司 固体剤形で非常に難溶性の薬物を調製する方法
US10137126B2 (en) 2015-06-29 2018-11-27 Yung Shin Pharm. Ind. Co., Ltd. Method of preparing very slightly soluble drug with solid dosage form

Also Published As

Publication number Publication date
CN1543359A (zh) 2004-11-03
US20040180961A1 (en) 2004-09-16
EP1409023A1 (en) 2004-04-21
KR20030003500A (ko) 2003-01-10
WO2003004060A1 (en) 2003-01-16
KR100425226B1 (ko) 2004-03-30

Similar Documents

Publication Publication Date Title
KR100425755B1 (ko) 이트라코나졸을 함유하는 조성물 및 그 제조방법
JP2004536108A (ja) アセクロフェナックを含有する経済的な経口用製剤の組成及び製法
Krstić et al. Self-nanoemulsifying drug delivery systems (SNEDDS) and self-microemulsifying drug delivery systems (SMEDDS) as lipid nanocarriers for improving dissolution rate and bioavailability of poorly soluble drugs
AU2014340710B2 (en) Compressed tablet containing delta 9-tetrahydrocannabinol, method for its manufacture and use of such tablet in oral treatment
JP2006511536A (ja) 水貧溶性薬物のバイオアベイラビリティーを改善する自由流動性固形製剤およびその製造方法
KR20130097172A (ko) 6’­플루오로­（Ｎ­메틸­ 또는 Ｎ，Ｎ­디메틸­）­4­페닐­4’，9’­디하이드로­3’Ｈ­스피로［사이클로헥산­1，1’­피라노［3，4，ｂ］인돌］­4­아민을 포함하는 약제학적 투여형
IL197701A (en) A solid composition containing nanotubes and a process for making them
EP1330244B1 (en) Compositions comprising modafinil compounds
CN102740841A (zh) 含有20-O-β-D-吡喃葡糖基-20(S)-原人参二醇的固体分散体
CN112353845B (zh) 含中药挥发油的热熔挤出组合物及其制备方法和药物制剂
US7749540B2 (en) Compositions comprising modafinil compounds
AU2003222437A1 (en) Pharmaceutical formulation in a drug delivery system and process for preparing the same
CN100463669C (zh) 复方蒿甲醚自乳化剂
HK1199829A1 (en) Micellar nanoparticles of chemical substances
KR20250129103A (ko) 자가유화 약학적 조성물, 그 제조 방법 및 그 용도
KR101859200B1 (ko) 모노아세틸디아실글리세롤 화합물의 경구 투여용 조성물 및 고형 제제
Aldosari Development and evaluation of self-nanoemulsifying drug delivery systems for oral delivery of indomethacin
JP2006509785A (ja) ビフェニルジメチルジカルボン酸の経口用マイクロエマルション組成物
US20060240051A1 (en) Eutectic blends containing a water soluble vitamin derivative
KR101058860B1 (ko) 수소화 코코-글리세라이드를 이용한 난용성 약물의 자가유화형 나노에멀젼 조성물
KR102329411B1 (ko) R-치옥트산 또는 이의 약학적으로 허용되는 염, 오일 및 분산보조제를 포함하는 약학조성물
JP2026501276A (ja) 親油性薬物の制御放出経口製剤
AU2002211677B2 (en) Compositions comprising modafinil compounds
HK1054688B (en) Compositions comprising modafinil compounds
CN102309476A (zh) 非诺贝特组合物

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20071113

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080722